SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193805-22-001680
Filing Date
2022-12-09
Accepted
2022-12-09 16:43:51
Documents
8

Document Format Files

Seq Description Document Type Size
1 e618097_s3-immunic.htm S-3 230361
2 e618097_ex5-1.htm EX-5.1 8644
3 e618097_ex23-1.htm EX-23.1 2102
4 e618097_ex107.htm EX-FILING FEES 17337
5 GRAPHIC image_001.jpg GRAPHIC 3167
6 GRAPHIC image_002.jpg GRAPHIC 22254
7 GRAPHIC image_003.jpg GRAPHIC 4789
8 GRAPHIC image_001.gif GRAPHIC 1763
  Complete submission text file 0001193805-22-001680.txt   304102
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

IRS No.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-268737 | Film No.: 221455338
SIC: 2834 Pharmaceutical Preparations